Arellano, Baby Girl .
HRN: 27-27-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/20/2025
06/26/2025
IV
40mg
OD
PSNB
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: